Manufacturing and Production

Showing 15 posts of 5860 posts found.

cmglee_cambridge_cancer_research_web

UK oral cancer rates soar 68% over two decades

November 29, 2016 Manufacturing and Production, Medical Communications, Research and Development Cancer Research UK, Oral cancer, mouth cancer

As a move to raise awareness during Mouth Cancer Action Month, Cancer Research UK (CRUK) has released figures of an …
shutterstock_232245868

Personalised medicine to drive global lung cancer market to 2020

November 29, 2016 Manufacturing and Production, Sales and Marketing Technavio, lung cancer, non-small cell lung cancer

According to a new report from Technavio, the global lung cancer therapeutics market is projected to grow at more than …
wockhardt_hospital_mumbai

Wockhardt UK sterile site hit with FDA warning

November 29, 2016 Manufacturing and Production FDA, Wockhardt, Wrexham

Mumbai-based pharmaceutical and biotechnology firm Wockhardt has been hit with more manufacturing woes as the FDA issued a warning letter …

FDA orphan drug designation doubles PhaseRx shares

November 28, 2016 Manufacturing and Production, Research and Development, Sales and Marketing FDA, Orphan Drug Designation, PhaseRx

PhaseRx is celebrating as its lead drug candidate PRX-OTC has been orphan drug designation by the US FDA for the …
shutterstock_57369385

Biosimilars and Generics: A no-brainer for treatment?

November 28, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biosimilars, generics

The industry is poised on the potential widespread adoption of many revolutionary technologies; foremost among them are biosimilars and generics, …
roche_florence_sc_site

Patheon acquires state-of-the-art manufacturing facility from Roche

November 28, 2016 Manufacturing and Production Patheon, Roche, South Carolina

Patheon, a provider of drug development and delivery to the pharmaceutical and biopharma sectors, announced that it has acquired a …
pfizer_building2web

Pfizer scraps €400m Dublin facility expansion

November 28, 2016 Manufacturing and Production, Sales and Marketing Pfizer, bococizumab

Pfizer has U-turned on its intention to bolster operations at its Grange Castle, Dublin facility in a 34,500 square-metre expansion …
uday_baldota

Taro announces appointment of new CEO

November 25, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Taro pharmaceutical, sun pharmaceutical

Taro Pharmaceutical announced that Uday Baldota will take up the position of CEO and will begin the role in early …
shutterstock_231613360

Non-small cell lung cancer market to hit $26bn by 2025

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GlobalData, non-small cell lung cancer

New research from GlobalData has indicated that the non-small cell lung cancer (NSCLC) market will rise in value by over …
navidea_cmyk

Navidea agrees deal worth $310 million with Cardinal

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cardinal, Navidea, Navidea biopharmaceutical

Navidea Biopharmaceuticals, a developer of immunodiagnostic agents and immunotherapeutics, has announced that they will enter into a definitive asset purchase …
juno

Patient deaths lead Juno Therapeutics to halt trial for second time

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing acute lymphoblastic leukaemia, clinical trial deaths, juno therapeutics

Juno Therapeutics has been forced to halt a trial investigating the efficacy of its lead experimental CAR-T cancer treatment JCAR015 …
lilly2_web

Lilly forced to abandon Alzheimer’s drug after failed trial

November 24, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Alzheimer's, Alzheimer's disease, Eli Lilly

Eli Lilly announced that the results of its ‘Expedition 3’ trial for an experimental Alzheimer’s disease drug meant that they would …
allergan

Allergan acquires Chase Pharma in potential $1 billion deal

November 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Allergan announced that it has completed the acquisition of Chase Pharmaceutical Corporation in a deal worth a potential $1 billion. …
anthony_maddaluna

Anthony Maddaluna, executive vice president of Pfizer, to retire

November 23, 2016 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Anthony J. Maddaluna, who worked at Pfizer for more than 41 years, will retire from his positions of executive vice …
The Gateway to Local Adoption Series

Latest content